Rna Expression Quantification
Rna Expression Quantification - Related Videos
10:39
Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification
0 Views •
Cited by 40 •
2016
This protocol describes the isolation and quantification of high-density lipoprotein small RNAs.
06:02
A Computational Pipeline for Intergenic/Intragenic Enhancer RNA Quantification in Mouse Embryonic Stem Cells
0 Views •
2025
This protocol provides a streamlined computational pipeline for quantifying nascent enhancer transcripts. By integrating chromatin accessibility, chromatin feature, and transcriptional data, it enables accurate detection and strand-specific analysis of enhancer activity in complex intragenic regions, while remaining accessible to researchers without extensive bioinformatics training.
09:26
Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
0 Views •
Cited by 2 •
2023
This protocol aims to quantify SARS-CoV-2 RNA in wastewater and air samples to be used for wastewater-based epidemiology studies and to assess the exposure risk to SARS-CoV-2 in indoor and outdoor aerosols. This protocol also describes a tiled amplicon long-template sequencing approach for SARS-CoV-2 whole genome characterization.
09:40
Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood
0 Views •
2018
Here, we present a protocol optimized for the processing of coding (mRNA) and non-coding (ncRNA) globin reduced RNA-seq libraries from a single whole blood sample.
11:52
Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
0 Views •
Cited by 15 •
2016
We describe a targeted RNA sequencing-based method that includes preparation of indexed cDNA libraries, hybridization and capture with custom probes and data analysis to interrogate selected transcripts for gene expression, mutations, and gene fusions. Targeted RNAseq permits cost-effective, rapid evaluation of selected transcripts on a desktop sequencer.
FAQs
The method first converts RNA into complementary DNA, or cDNA, and then amplifies that material. Measuring the amplified cDNA provides a basis for estimating the abundance of the original RNA molecules. This workflow is useful when bioengineers need to examine expression changes in engineered cells or assess responses following a genetic intervention.
RNA sequencing produces sequence reads that must be aligned so they can be associated with transcripts. The resulting abundance estimates are then normalized across samples, allowing expression patterns to be compared more meaningfully. In bioengineering studies, this supports evaluation of how engineered systems or biomaterials influence coordinated gene activity rather than isolated transcript measurements.
Reverse-transcription quantitative PCR measures RNA through cDNA conversion and amplification, whereas RNA sequencing estimates transcript abundance from sequence reads. The methods therefore provide different measurement workflows for studying expression. Selecting between them depends on the experimental question, such as evaluating targeted expression changes with amplification or examining transcript abundance across a broader sequence-based profile.
Normalization places expression estimates from different samples on a comparable basis. In RNA sequencing, it follows alignment of sequence reads and helps researchers interpret differences between samples rather than treating raw measurements as directly equivalent. This is particularly relevant when comparing engineered cells, biomaterial responses, or genetic interventions across experimental conditions.
A typical workflow begins with RNA from a biological sample, followed by either conversion to cDNA and amplification for reverse-transcription quantitative PCR or generation of sequence reads for RNA sequencing. Sequencing data are aligned and normalized across samples. The resulting measurements can then be compared to evaluate expression patterns in the selected biological system.
Bioengineers can use these measurements to characterize engineered cells and determine how genetic interventions or biomaterials affect gene activity. Expression results may reveal responses associated with tissue formation, disease models, or biomanufacturing. Such comparisons help connect an engineered condition with molecular changes and provide evidence for evaluating or refining the biological design.
Expression data provide molecular evidence for assessing whether an engineered construct produces the intended biological response. By comparing transcript abundance across conditions, researchers can characterize pathway activity and monitor responses relevant to tissue formation or disease models. This information supports construct optimization and contributes to the development of cell-based therapies and diagnostic systems.